iifl-logo

Glenmark Pharmaceuticals Ltd Historical Data

Add as a Preferred Source on Google
2,413.9
(0.42%)
Apr 29, 2026|05:30:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

Glenmark Pharmaceuticals Ltd Historical Data

29/03/2026calendar-icon
29/04/2026calendar-icon
Date
Open(₹)
High(₹)
Low(₹)
Close(₹)
No. Of Trades(₹)
Total Turnover(₹)
Deliverable Quantity(₹)

30-Mar-2026

2,169.5

2,170.82,108.72,131.753,9042,57,34,99,9677,37,306

01-Apr-2026

2,180

2,238.42,0852,101.169,2162,18,48,66,318.25,05,518

02-Apr-2026

2,085

2,098.41,966.52,091.856,2591,96,55,66,542.63,90,712

06-Apr-2026

2,079.3

2,112.82,036.72,104.840,0681,21,46,26,147.81,87,023

07-Apr-2026

2,100

2,1382,068.22,114.139,51581,80,57,373.61,95,719

08-Apr-2026

2,165

2,1872,129.62,173.543,4401,17,42,29,0122,67,060

09-Apr-2026

2,173.5

2,186.22,1422,169.146,8281,32,62,58,148.63,56,991

10-Apr-2026

2,173.9

2,198.92,148.92,163.244,1331,45,19,84,931.93,82,606

13-Apr-2026

2,153.4

2,2052,115.12,193.142,1631,57,47,38,175.53,63,372

15-Apr-2026

2,230.9

2,2652,2052,258.441,8431,38,26,77,924.53,26,739

16-Apr-2026

2,267

2,273.82,228.62,249.534,50397,55,52,101.51,81,826

17-Apr-2026

2,249.5

2,274.92,240.92,249.535,18982,55,01,158.31,83,200

20-Apr-2026

2,249.5

2,250.52,210.52,230.733,42091,01,97,836.82,35,189

21-Apr-2026

2,221.9

2,2452,215.22,233.127,19156,90,83,895.11,36,149

22-Apr-2026

2,233.1

2,2472,204.82,24018,32271,86,85,3311,55,110

23-Apr-2026

2,247.9

2,359.42,212.12,33584,5873,94,35,63,6784,68,479

24-Apr-2026

2,351

2,372.82,283.22,299.551,2541,94,83,53,615.42,75,925

27-Apr-2026

2,312

2,339.92,290.92,325.127,5011,07,14,29,887.51,79,514

28-Apr-2026

2,328.1

2,427.42,327.32,403.769,8963,69,11,62,502.96,11,689

Glenmark Pharma.: Related NEWS

Glenmark Pharma Q3 FY26 Profit Rises 16% to ₹403.2 Crore

Revenue from North America increased 24% year on year to ₹970.6 crore, including income from the out licensing of ISB 2001.

31 Jan 2026|02:22 PM
Read More
Top Stocks for Today - 25th September 2025

Here are some of the stocks that may see significant price movement today: Polycab India, Tata Steel, Dalmia Bharat, etc.

25 Sep 2025|06:57 AM
Read More
Top Stocks for Today - 23rd September 2025

Here are some of the stocks that may see significant price movement today: Glenmark Pharma, Rail Vikas Nigam, Birla Corp, etc.

23 Sep 2025|07:01 AM
Read More
Glenmark subsidiary gets $700 Million in licensing deal; stock gains

At around 2.19 PM, Glenmark Pharma was trading 2.97% higher at ₹2,112.90 per piece, against the previous close of ₹2,051.90 on NSE.

9 Sep 2025|02:31 PM
Read More
Glenmark Pharma Q1 Net Profit Falls 86% YoY to ₹47 Crore

Operating performance was slightly weaker, with EBITDA dipping 1.4% to ₹580 crore from ₹588.2 crore.

18 Aug 2025|01:03 PM
Read More
Top Stocks for Today - 18th August 2025

Here are some of the stocks that may see significant price movement today: Glenmark Pharmaceuticals, Vedanta, Inox Wind, etc.

18 Aug 2025|08:14 AM
Read More
Glenmark Shares Surge 10% After AbbVie Inks Licensing Deal for ISB 2001

The compound is currently in Phase 1B clinical trials, being studied for multiple myeloma, a tough-to-treat form of blood cancer.

11 Jul 2025|09:48 AM
Read More
Top Stocks for Today - 11th July 2025

Here are some of the stocks that may see significant price movement today: Tata Consultancy Services, IREDA, Glenmark Pharma, etc.

11 Jul 2025|07:20 AM
Read More
Top Stocks for Today - 26th May 2025

Here are some of the stocks that may see significant price movement today: Glenmark Pharma, Ashok Leyland, NTPC, etc.

26 May 2025|06:34 AM
Read More
Glenmark Pharma’s cancer drug receive FDA ‘fast track’ status

ISB 2001 is a tri-specific antibody therapeutic for targeting BCMA and CD38 on myeloma cells, as well as CD3 on T cells.

6 May 2025|09:31 AM
Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.